» Authors » David Landau

David Landau

Explore the profile of David Landau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 1104
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Erdinest N, Ben Ephraim-Noyman D, Shmueli O, Landau D, Lavy I, Solomon A
Harefuah . 2025 Feb; 164(1):39-45. PMID: 39931019
The importance of early detection of keratoconus lies in early treatment to prevent complications resulting from disease progression and in planning optimal follow-up or screening schedules for family members, considering...
2.
Tsouknidas I, Volteas P, Kokkosis A, Price J, Tassiopoulos A, Landau D
J Vasc Surg Cases Innov Tech . 2024 Sep; 10(6):101612. PMID: 39323651
A 68-year-old female with extensive medical and surgical history, including open and endovascular procedures, presented with chronic limb-threatening ischemia, hypertension, and chronic mesenteric ischemia. A computed tomographic angiogram showed significant...
3.
Erdinest N, Lavy I, London N, Levinger N, Atar Vardi M, Shemer A, et al.
Harefuah . 2024 May; 163(5):278-285. PMID: 38734939
Introduction: The importance of myopia management lies in the desire to minimize the potential ocular risks that increase with high myopia. Aims: To assess the decrease in myopia progression using...
4.
Erdinest N, London N, Landau D, Barbara R, Barbara A, Naroo S
Int Ophthalmol . 2024 Apr; 44(1):172. PMID: 38594548
Introduction: Keratoconus is a progressive disorder of the cornea that causes thinning (Sedaghat et al. in Sci Rep 11(1):11971, 2021), ectasia, and irregular astigmatism, resulting in poor visual acuity that...
5.
Erdinest N, Noyman D, London N, Lavy I, Levinger N, Landau D, et al.
Int Ophthalmol . 2024 Mar; 44(1):157. PMID: 38522059
Purpose: This meta-analysis aimed to review the safety and efficacy of topical cyclosporine A (CsA) and topical tacrolimus in allergic eye disease. Methods: A systematic search identified thirteen studies and...
6.
Erdinest N, Atar-Vardi M, London N, Landau D, Smadja D, Pras E, et al.
Vision (Basel) . 2024 Feb; 8(1). PMID: 38391084
This retrospective study evaluates the effectiveness of combining 0.05% atropine with MF60 contact lenses in managing rapid myopia progression in children over one year. The study involved three groups: the...
7.
Erdinest N, Noyman D, Lavy I, Berkow D, Pincovich S, London N, et al.
Harefuah . 2024 Jan; 163(1):37-42. PMID: 38297419
Artificial intelligence (AI) was first introduced in 1956, and effectively represents the fourth industrial revolution in human history. Over time, this medium has evolved to be the preferred method of...
8.
Erdinest N, Atar-Vardi M, Lavy I, London N, Landau D, Pras E, et al.
J Pediatr Ophthalmol Strabismus . 2023 Dec; 61(3):204-210. PMID: 38112389
Purpose: To ascertain the effectiveness of 0.01% atropine treatment to inhibit myopia progression and the possible additive potency with peripheral defocus contact lenses over 3 years and the rebound effect...
9.
Erdinest N, London N, Lavy I, Berkow D, Landau D, Levinger N, et al.
Taiwan J Ophthalmol . 2023 Dec; 13(3):285-292. PMID: 38089507
Myopia is the most common refractive error in the world and has reached a pandemic level. The potential complications of progressive myopia have inspired researchers to attempt to understand the...
10.
Erdinest N, London N, Lavy I, Berkow D, Landau D, Morad Y, et al.
Korean J Ophthalmol . 2023 Feb; 37(1):70-81. PMID: 36796348
Myopia is the most common refractive error in the world, and its' prevalence continually increases. The potential pathological and visual complications of progressive myopia have inspired researchers to study the...